Insufficient scRNA-seq data for expression of INCA1 at single-cell level.
Insufficient scRNA-seq data for expression of INCA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 138.38 | 2633 / 2642 | 100% | 13.64 | 704 / 705 |
prostate | 100% | 208.00 | 245 / 245 | 99% | 16.04 | 499 / 502 |
ovary | 100% | 226.95 | 180 / 180 | 98% | 8.25 | 423 / 430 |
thymus | 100% | 318.51 | 653 / 653 | 98% | 10.99 | 594 / 605 |
breast | 100% | 146.00 | 459 / 459 | 97% | 11.49 | 1090 / 1118 |
kidney | 100% | 167.03 | 89 / 89 | 96% | 8.90 | 865 / 901 |
skin | 100% | 109.90 | 1805 / 1809 | 96% | 7.00 | 454 / 472 |
lung | 100% | 185.92 | 578 / 578 | 94% | 5.53 | 1086 / 1155 |
intestine | 100% | 191.42 | 966 / 966 | 92% | 4.54 | 483 / 527 |
esophagus | 100% | 160.63 | 1441 / 1445 | 92% | 5.02 | 168 / 183 |
stomach | 100% | 124.91 | 359 / 359 | 90% | 4.53 | 258 / 286 |
pancreas | 95% | 62.55 | 310 / 328 | 96% | 5.88 | 170 / 178 |
bladder | 100% | 160.52 | 21 / 21 | 86% | 4.57 | 433 / 504 |
adrenal gland | 99% | 98.19 | 256 / 258 | 87% | 5.71 | 199 / 230 |
uterus | 100% | 233.99 | 170 / 170 | 82% | 4.64 | 375 / 459 |
liver | 99% | 98.65 | 223 / 226 | 58% | 2.41 | 234 / 406 |
muscle | 100% | 229.82 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 249.53 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 164.24 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 128.23 | 1202 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 6.88 | 79 / 80 |
heart | 98% | 155.39 | 848 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 5.49 | 24 / 29 |
tonsil | 0% | 0 | 0 / 0 | 73% | 3.01 | 33 / 45 |
peripheral blood | 42% | 39.09 | 393 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0045736 | Biological process | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
GO_0048144 | Biological process | fibroblast proliferation |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0004861 | Molecular function | cyclin-dependent protein serine/threonine kinase inhibitor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0030332 | Molecular function | cyclin binding |
Gene name | INCA1 |
Protein name | Protein INCA1 (Inhibitor of CDK interacting with cyclin A1) |
Synonyms | HSD45 |
Description | FUNCTION: Binds to CDK2-bound cyclins and inhibits the kinase activity of CDK2; binding to cyclins is critical for its function as CDK inhibitor . Inhibits cell growth and cell proliferation and may play a role in cell cycle control (By similarity). Required for ING5-mediated regulation of S-phase progression, enhancement of Fas-induced apoptosis and inhibition of cell growth (By similarity). . |
Accessions | ENST00000355025.7 [Q0VD86-2] ENST00000574617.1 [Q0VD86-1] ENST00000695324.1 [Q0VD86-1] Q0VD86 ENST00000576820.5 [Q0VD86-1] ENST00000575780.5 [Q0VD86-2] |